Join us at the #PHLEX Summit, the home for biopharma launch leaders from commercial, medical, clinical, and operational functions to revolutionize launch strategy & management from clinical development into post-launch commercial success.

Immerse yourself in a dynamic program filled with insightful sessions led by top pharma launch leaders from renowned organizations like Novartis, AstraZeneca, Ipsen, Takeda, Helsinn Group, Gilead Sciences, Novo Nordisk, and more. By fostering collaboration, knowledge sharing, and networking, this comprehensive agenda empowers you to enhance processes, fine-tune strategies, and tackle challenges in today’s fast-paced environment, maximizing patient impact and commercial success.

Don’t miss this opportunity to lead the way in launch excellence - Download your complimentary copy of the 2024 event guide now >>

The 2025 State of Pharma Launch Excellence Industry Report has just been released, and you can download it now.

The pharmaceutical landscape is evolving rapidly, with more launches failing than ever before. This brand new report - the most detailed and accurate to date - provides a full update on the current state of pharmaceutical launches, examining why these failures are occurring, which specific launches are struggling, and what strategies companies are implementing to overcome these challenges. This comprehensive analysis names key drugs, organisations, and insights to help you navigate regulatory hurdles and position your launches for success in this evolving landscape.

Download your complimentary copy of the brand new 45 page report now for an in-depth look at:

• How generative AI is transforming pharma launch strategies
• Key therapeutic areas like oncology, immunology, and obesity treatments leading future launches
• Navigating new regulatory challenges, including U.S. price controls and European reforms
• The critical role of cross-functional coordination in achieving launch success
• Why specialty drugs continue to dominate market growth
• The rise of independent launches by smaller biotech firms
• Addressing healthcare system capacity issues amid rising specialty drug costs
  

The 2025 State of Pharma Launch Excellence Industry Report has just been released, and you can download it now.

The pharmaceutical industry is entering a pivotal phase as launches grow more complex, particularly with the rise of specialty drugs and cutting-edge therapies like antibody-drug conjugates (ADCs), cell and gene therapies, and mRNA-based treatments. In 2025, the adoption of generative AI and advanced digital tools will significantly accelerate the launch process, driving faster development times, enhancing decision-making, and boosting patient engagement. Companies that can harness these technologies while navigating regulatory hurdles and healthcare system challenges will be best positioned for success in this evolving landscape.

Download your complimentary copy of the brand new 45 page report now for an in-depth look at:

• How generative AI is transforming pharma launch strategies
• Key therapeutic areas like oncology, immunology, and obesity treatments leading future launches
• Navigating new regulatory challenges, including U.S. price controls and European reforms
• The critical role of cross-functional coordination in achieving launch success
• Why specialty drugs continue to dominate market growth
• The rise of independent launches by smaller biotech firms
• Addressing healthcare system capacity issues amid rising specialty drug costs
  

Dive into an exclusive interview with Sherif Elhaw, Pfizer's Launch Excellence Lead for Emerging Markets. With over two decades of experience in pharmaceuticals, Sherif shares his journey, the evolution of launch strategies, and the pivotal role of innovation in overcoming industry challenges. Gain valuable insights into navigating the complexities of product launches and discover how to harness critical thinking and data analytics for successful outcomes. Download this content to empower your approach to drug launches and stay ahead in the dynamic pharmaceutical landscape. Don't miss the opportunity to learn from a leader at the forefront of healthcare innovation!

#PHLEX is set to unite the global launch community to navigate post-pandemic challenges in a competitive digital and regulatory environment, optimising strategy for successful product commercialisation. See who you could be connecting with at the Pharma Launch Excellence Summit this December in London! 

Get your complimentary copy below